How are insulin adjustments made for patients with uncontrolled glucose levels?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Insulin Adjustments for Patients with Uncontrolled Glucose Levels

Insulin adjustments for patients with uncontrolled glucose should follow a systematic approach based on blood glucose patterns, with basal insulin starting at 10 units or 0.1-0.2 units/kg and titration based on self-monitoring of blood glucose (SMBG) levels. 1

Initial Insulin Therapy Approach

Starting Basal Insulin

  • Begin with basal insulin at 10 units or 0.1-0.2 units/kg/day, depending on the degree of hyperglycemia 1
  • Typically prescribed with metformin and possibly one additional non-insulin agent 1
  • Set fasting plasma glucose (FPG) goals and choose an evidence-based titration algorithm 1
  • Increase by approximately 2 units every 3 days to reach FPG goal without hypoglycemia 1
  • If hypoglycemia occurs, determine the cause; if no clear reason is found, reduce dose by 10-20% 1

When to Consider Insulin Initiation

  • Consider starting insulin when A1C ≥9% 1
  • Start immediately when blood glucose ≥300-350 mg/dL (16.7-19.4 mmol/L) or A1C ≥10-12%, especially if symptomatic 1
  • In cases of severe hyperglycemia with ketosis or unintentional weight loss, basal insulin plus mealtime insulin is the preferred initial regimen 1

Adjusting Insulin Therapy When Goals Are Not Met

When Basal Insulin Is Insufficient

  • If basal insulin has been titrated to acceptable fasting blood glucose but A1C remains above target, advance to combination injectable therapy 1
  • Options include:
    1. Adding a GLP-1 receptor agonist 1
    2. Adding mealtime insulin (prandial insulin) 1
    3. Switching to twice-daily premixed insulin 1

Adding Prandial Insulin

  • Start with one dose with the largest meal or meal with greatest postprandial glucose excursion 1
  • Initial dose: 4 units per day or 10% of basal insulin dose 1
  • Increase dose by 1-2 units or 10-15% based on postprandial glucose readings 1
  • If A1C <8%, consider lowering the basal dose by 4 units or 10% when adding prandial insulin 1
  • For hypoglycemia, determine cause; if no clear reason, lower corresponding dose by 10-20% 1

Full Basal-Bolus Regimen

  • When stepping up to multiple daily injections, consider the following distribution 1:
    • Total insulin dose: divide as 50% basal and 50% prandial, with prandial insulin split evenly between meals 1
    • For premixed insulin plans: typically 2/3 before breakfast and 1/3 before dinner 1

Monitoring and Adjusting Insulin Therapy

Self-Monitoring of Blood Glucose (SMBG)

  • Equipping patients with an algorithm for self-titration based on SMBG improves glycemic control 1
  • Adjustments to both basal and prandial insulins should be based on prevailing blood glucose levels 1
  • Pattern control requires understanding the pharmacodynamic profile of each insulin formulation 1

Continuous Glucose Monitoring (CGM)

  • CGM provides real-time insights into glucose dynamics and trends, which can guide more precise insulin adjustments 2
  • When using CGM data, patients often make larger insulin adjustments than commonly recommended:
    • For rapidly rising glucose (>3 mg/dL/minute), patients may increase correction bolus by up to 140% 3
    • For rapidly falling glucose (>3 mg/dL/minute), patients typically reduce dose by 42% 3

Special Considerations

Hypoglycemia Management

  • If hypoglycemia occurs, determine the cause and reduce the insulin dose by 10-20% if no clear reason is identified 1
  • Patients should carry at least 15g of carbohydrate to treat hypoglycemic episodes 1
  • Family members should be instructed in glucagon use for severe hypoglycemia 1

Insulin Administration Sites

  • Rotation of injection sites is important to prevent lipohypertrophy or lipoatrophy 1
  • Systematic rotation within one area (e.g., abdomen) is recommended rather than rotating between different areas 1
  • Absorption rates differ by site: abdomen (fastest) > arms > thighs > buttocks 1
  • Exercise increases absorption rates from injection sites 1

During Illness

  • Continue insulin even when the patient is unable to eat or is vomiting 1
  • More frequent SMBG may be required during illness, travel, or changes in routine 1

Adjustments in Hospital Settings

For Critically Ill Patients

  • Use intravenous insulin infusion with a starting threshold of no higher than 180 mg/dL 1
  • Maintain glucose levels between 140-180 mg/dL (7.8-10.0 mmol/L) 1
  • Lower targets (120-140 mg/dL) may be appropriate in select patients 1

For Non-Critically Ill Patients

  • Target premeal glucose <140 mg/dL (7.8 mmol/L) 1
  • Target random blood glucose <180 mg/dL (10.0 mmol/L) 1
  • Reassess insulin regimen if blood glucose falls below 100 mg/dL (5.6 mmol/L) 1
  • Modify regimen when blood glucose values are <70 mg/dL (3.9 mmol/L) 1

By following these structured approaches to insulin adjustment, clinicians can effectively manage uncontrolled glucose levels while minimizing the risk of hypoglycemia and optimizing patient outcomes.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

HOW PATIENTS WITH TYPE 1 DIABETES TRANSLATE CONTINUOUS GLUCOSE MONITORING DATA INTO DIABETES MANAGEMENT DECISIONS.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2015

Related Questions

What adjustments should be made to the medication regimen of an 88-year-old patient with an Hemoglobin A1C (HbA1c) level of 8.0%, experiencing blood glucose variability, and currently being treated with metformin (Metformin), Jardiance (Empagliflozin), Januvia (Sitagliptin), and Lantus (Insulin Glargine) for diabetes management?
What should be included in a home monitoring chart for a diabetic patient to track blood sugar levels?
Is a 28-day Continuous Glucose Sensor (CGS) prescription with 2 dispensed and 3 refills appropriate for managing diabetes?
How to manage a patient with hyperglycemia and low total protein and globulin levels?
What advice can be given to a 61-year-old male with type 1 diabetes mellitus (DM), hypertension, hyperlipidemia, anxiety, vitamin D deficiency, and reactive airway disease, presenting with hyperglycemia, elevated cholesterol, and fatigue, who has not been using his insulin/long-acting insulin therapy since February 2025 due to cost?
Should I take Atorvastatin (Atrova) before surgery?
Can minoxidil (oral or topical) cause erectile dysfunction (impotence)?
Which Non-Steroidal Anti-Inflammatory Drug (NSAID) has the lowest risk of Gastrointestinal (GI) bleed?
What about using celecoxib (a nonsteroidal anti-inflammatory drug (NSAID)) for patients at high risk of gastrointestinal bleeding?
What are the dosages for Oseltamivir (antiviral medication) in the treatment of influenza A?
What is the mechanism of action of Minoxidil (minoxidil) for promoting hair growth?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.